No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes using non‐steroidal anti‐inflammatory drugs

There is little evidence on whether non‐steroidal anti‐inflammatory drugs (NSAIDs) and aspirin interact in secondary cardiovascular prevention in type 2 diabetic patients. This is an observational study using data from the Action to Control Cardiovascular Risk in Diabetes and Follow‐on studies. Haza...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsujimoto, Tetsuro, Kajio, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767776/
https://www.ncbi.nlm.nih.gov/pubmed/30941845
http://dx.doi.org/10.1111/dom.13737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767776/
https://www.ncbi.nlm.nih.gov/pubmed/30941845
http://dx.doi.org/10.1111/dom.13737

Ejemplares similares